No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects
1996 ◽
Vol 76
(02)
◽
pp. 166-170
◽
Keyword(s):
Keyword(s):
1997 ◽
Vol 247
(6)
◽
pp. 297-302
◽